梅利丁作为类风湿性关节炎的治疗剂:机械学见解,先进的输送系统和未来的前景
Ashutosh Pareek1, Khushbu Mehlawat1, Kritika Tripathi1
1Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.
Frontiers in immunology
|January 6, 2025
概括
蜜蜂毒液,特别是梅利丁,通过减少关节损伤,显示出治疗类风湿性关节炎 (RA) 的前景. 新的交付系统正在开发,以克服 melittin.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
- 生物化学 生化学
背景情况:
- 风湿性关节炎 (RA) 是一种全球性疾病,通过矩阵金属蛋白酶 (MMP) 引起关节恶化.
- 蜜蜂毒 (BV) 是一种传统中医药治疗关节炎和疼痛的药物,含有梅利丁和酸酶A2 (PLA2).
研究的目的:
- 审查蜜蜂毒 (BV) 的组成和抗关节炎机制,重点关注梅利丁.
- 探索克服梅利丁在风湿性关节炎 (RA) 管理中的治疗限制的新策略.
主要方法:
- 关于蜜蜂毒液 (BV) 组成和抗关节炎特性的当前文献的综述.
- 分析梅利丁的分子机制,包括NF-κB,MMP和TNF-α抑制.
- 检查melittin的先进输送系统,如纳米载体和透皮贴片.
主要成果:
- 梅利丁是一种主要的BV成分,降低NF-κB的调节,抑制MMP-1和MMP-8,并减少TNF-α,减轻原体的降解.
- 梅利丁的治疗应用受其溶血活性和细胞膜毒性限制.
- 新的输送系统 (纳米载体,皮肤贴片,纳米乳液) 正在开发中,以提高梅利丁对RA的安全性和有效性.
结论:
- 梅利丁具有显著的抗关节炎潜力,通过向类风湿性关节炎 (RA) 中的关键炎症途径.
- 通过先进的输送系统克服梅利丁的毒性对于其在RA治疗中的临床应用至关重要.
- 对新策略的持续研究强调了梅利丁在治疗类风湿性关节炎中的不断变化的作用.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Drug Delivery: Miscellaneous Routes
309
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
309
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


